# OnCo record lymphoma-tx-pod24 (term). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/terms/lymphoma-tx-pod24/>
  a schema:DefinedTerm ;
  onco:kind "term" ;
  schema:identifier "lymphoma-tx-pod24" ;
  schema:name "POD24: progression of follicular lymphoma within two years, and why it changes the plan"@en ;
  schema:alternateName "Progression of disease within 24 months"@en, "Early progression follicular lymphoma"@en ;
  schema:description "Most follicular lymphoma comes back slowly and is treated again without much loss of life expectancy. For about one in five people it comes back within two years of the first chemotherapy, and that group needs a different plan, usually a biopsy first and then cellular or antibody treatment rather than more of the same."@en ;
  schema:url <https://onco.cc/terms/lymphoma-tx-pod24/> ;
  schema:dateModified "2026-09-29"^^xsd:date ;
  schema:citation <https://doi.org/10.1200/JCO.2014.59.7534>, <https://doi.org/10.1038/s41591-021-01622-0> ;
  onco:cancers <https://onco.cc/cancers/follicular-lymphoma/>, <https://onco.cc/cancers/non-hodgkin-lymphoma/>, <https://onco.cc/cancers/marginal-zone-lymphoma/> ;
  onco:drugs <https://onco.cc/drugs/axicabtagene-ciloleucel/>, <https://onco.cc/drugs/tisagenlecleucel/>, <https://onco.cc/drugs/mosunetuzumab/>, <https://onco.cc/drugs/odronextamab/>, <https://onco.cc/drugs/epcoritamab/>, <https://onco.cc/drugs/lenalidomide/>, <https://onco.cc/drugs/rituximab/> ;
  onco:terms <https://onco.cc/terms/flipi/>, <https://onco.cc/terms/lymphoma-tx-transplant-role/>, <https://onco.cc/terms/lymphoma-tx-car-t-pathway/> ;
  onco:trials <https://onco.cc/trials/zuma-5/>, <https://onco.cc/trials/augment/> .